UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, DC 20549
___________
FORM 8-K
___________
CURRENT REPORT
Pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September
28, 2009
Commission File Number: 333- 141327
CHINA DASHENG
BIOTECHNOLOGY COMPANY
(Exact name of small
business issuer as specified in its charter)
Nevada
26-0162321
(State or other
jurisdiction of incorporation or organization)
(IRS Employer
Identification No.)
China Dasheng
Biotechnology Company
Building B 17th Floor
Century Plaza
Qingyang Road
Lanzhou, Gansu
People's Republic of
China
Telephone number:
(86)931 8441248
(Address of principal
executive offices including Zip Code)
Gang Chen
China Dasheng
Biotechnology Company
Building B 17th Floor
Century Plaza
Qingyang Road
Lanzhou, Gansu
People's Republic of
China
Telephone number:
(86)931 8441248
(Agent's office and
telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR.425)
o
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
On September 28, 2009, the Board of
Directors of China Dasheng Biotechnology (the “Company”) appointed Mr. Gang
Chen as Chairman of the Board and Chief Executive Officer and the Company. On
the same day Mr. Jinjun Qi resigned as Chairman of the Board and a director and
Sidong Zhang resigned as Chief Executive Officer and as a director. The
resignations were not as a result of any disagreements with us.
Mr. Gang Chen, age 46, has been employed
by the Company’s subsidiary Dasheng Biotechnology since June 1986 and prior
thereto was president of Gangsu Ritong Electronic Company from 1999 to 2008.
Mr. Gang received a BA in economics and management in 1984 from Lanzhou
University in 1991.
The Company has not entered into any
employment agreements with Mr. Gang Chen.
Item 9.01 Financial Statements And Exhibits.
(a) Financial Statements of Business Acquired. None
(b) Pro Forma Financial Information. None
(c) Shell Company Transactions. None
(d) Exhibits. None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: October 6, 2009
CHINA DASHENG BIOTECHNOLOGY COMPANY
By: /s/ Gang Chen
Name: Gang Chen
Title: CEO